dalteparin has been researched along with Apnea, Obstructive Sleep in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"Acute pulmonary embolism (PE) may result in an increase in central venous pressure, which may contribute to pharyngeal narrowing by fluid accumulation in nuchal and peripharyngeal soft tissues and therefore affect obstructive sleep apnoea (OSA)." | 1.38 | Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing? ( Berghaus, TM; Faul, C; Schwaiblmair, M; Thilo, C; Unterer, F; von Scheidt, W, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berghaus, TM | 1 |
Faul, C | 1 |
Unterer, F | 1 |
Thilo, C | 1 |
von Scheidt, W | 1 |
Schwaiblmair, M | 1 |
1 other study available for dalteparin and Apnea, Obstructive Sleep
Article | Year |
---|---|
Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing?
Topics: Acute Disease; Aged; Airway Resistance; Anticoagulants; Central Venous Pressure; Enoxaparin; Female; | 2012 |